CareCloud (MTBC) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Mar, 2026Executive summary
Achieved strong financial growth in 2025 with revenue up 8.7% to $120.5M and net income up 37.5% to $10.8M, surpassing guidance and marking the first full-year positive GAAP EPS since IPO.
Strategic acquisitions, including Medsphere and MAP App, expanded the platform into the inpatient hospital market and were fully funded by free cash flow, with no year-end debt or shareholder dilution.
Launched an AI Center of Excellence and deployed production-grade AI across the platform, automating up to 75% of inbound calls and driving early adoption.
Recurring revenue streams and AI integration provided predictability and positioned the company for continued momentum entering 2026.
Fully repaid credit line and paid 13 consecutive monthly preferred dividends from free cash flow.
Financial highlights
Full year 2025 revenue reached $120.5M, up 8.7% year-over-year; Q4 revenue was $34.4M, up 21.9%.
GAAP net income for 2025 was $10.8M, a 37.5% increase year-over-year; Q4 net income was $2.9M.
Adjusted EBITDA for 2025 was $27.5M (23% margin), up 14.5% year-over-year; Q4 adjusted EBITDA was $7.7M.
Free cash flow for 2025 was $20.5M, up 55% from 2024 and over 400% from 2022.
First full year of positive GAAP EPS ($0.10); Q4 EPS was $0.04.
Outlook and guidance
2026 revenue guidance: $128M–$132M; adjusted EBITDA: $29M–$31M, reflecting margin expansion.
GAAP EPS expected at $0.20–$0.23, more than doubling 2025 results.
Guidance does not include any unannounced material acquisitions.
CapEx and capitalized software spending expected to be flat or slightly lower than 2025.
Four strategic priorities for 2026: expand AI suite, execute cross-sell, build AI infrastructure, and drive client outcomes.
Latest events from CareCloud
- AI-powered healthcare IT solutions drive growth, efficiency, and expanded market reach.MTBC
Investor presentation12 Mar 2026 - First positive GAAP net income since 2022, with strong EBITDA and free cash flow growth.MTBC
Q2 20241 Feb 2026 - Record free cash flow and profitability support dividend resumption and margin growth.MTBC
Q3 202415 Jan 2026 - Record 2024 profit, cash flow, and AI innovation drive 2025 growth outlook.MTBC
Q4 202425 Dec 2025 - AI-driven healthcare platform achieves record free cash flow and resumes strategic acquisitions.MTBC
15th Annual LD Micro Invitational 202524 Dec 2025 - AI Desk Agent automates 80% of patient calls, driving efficiency, savings, and rapid ROI.MTBC
Status Update18 Dec 2025 - Registering up to $250M in securities to drive healthcare tech growth and industry consolidation.MTBC
Registration Filing16 Dec 2025 - Vote proposed to increase authorized shares to 85 million, supporting growth and acquisitions.MTBC
Proxy Filing1 Dec 2025 - Shareholders to vote on aligning Series A Preferred Stock terms with Series B, including a dividend cut.MTBC
Proxy Filing1 Dec 2025